Johnson Pharma

{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.57",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.57",
    "mcapval": "31.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE560F01022",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "10.89 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Johnson Pharmacare Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-johnson-pharmacare-ltd-fallingrising-3838693",
        "imagepath": "",
        "date": "2026-02-14 01:08:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Johnson Pharmacare’s share price decline on 13-Feb contrasts with its mixed performance over various time frames. While the stock has slipped by 1.67% over the past week, this underperformance is slightly more pronounced than the Sensex’s 1.14% drop during the same period. However, the stock has outperformed the benchmark over the last month and year-to-date, registering gains of 5.36% and 1.72% respectively, compared to the Sensex’s negative returns of 1.20% and 3.04% over those intervals.</p>\n<p>Despite these short-term gains, the stock’s one-year performance remains a significant concern for investors, having declined by 42.16%, while the Sensex has appreciated by 8.52%. Over longer horizons, Johnson Pharmacare has delivered impr..."
      },
      {
        "title": "When is the next results date for Johnson Pharmacare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-johnson-pharmacare-ltd-3838641",
        "imagepath": "",
        "date": "2026-02-13 23:15:43",
        "description": "The next results date for Johnson Pharmacare Ltd is scheduled for 14 February 2026...."
      }
    ],
    "total": 80,
    "sid": "233635",
    "stock_news_url": "https://www.marketsmojo.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "17-Apr-2026",
      "details": "Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Apr-2026",
      "details": "Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment of mr. Dheeraj Kumar as Additional Executive Director.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "17-Apr-2026",
      "details": "1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April 2026 The Board has appointed Mr. Dheeraj Kumar (DIN: 11666616) as an Additional (Executive Director) of the Company w.e.f 17th April 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/2015 dated September 09 2015 is enclosed as (Attached herewith as Annexure) The Board has considered and approved resignation of Mr. Rajender Parsad (DIN: 10871533) as an Additional & Non-Executive Director of the Company w.e.f 17th April 2026 The Board has considered and approved resignation of Mr. Umesh Kumar (DIN: 07015921) as an Additional & Executive Director of the Company w.e.f 17th April 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Johnson Pharmacare Ltd falling/rising?

2026-02-14 01:08:32

Recent Price Movement and Market Comparison

Johnson Pharmacare’s share price decline on 13-Feb contrasts with its mixed performance over various time frames. While the stock has slipped by 1.67% over the past week, this underperformance is slightly more pronounced than the Sensex’s 1.14% drop during the same period. However, the stock has outperformed the benchmark over the last month and year-to-date, registering gains of 5.36% and 1.72% respectively, compared to the Sensex’s negative returns of 1.20% and 3.04% over those intervals.

Despite these short-term gains, the stock’s one-year performance remains a significant concern for investors, having declined by 42.16%, while the Sensex has appreciated by 8.52%. Over longer horizons, Johnson Pharmacare has delivered impr...

Read full news article

When is the next results date for Johnson Pharmacare Ltd?

2026-02-13 23:15:43

The next results date for Johnson Pharmacare Ltd is scheduled for 14 February 2026....

Read full news article

View All News